(Q35319290)

7 August 2017

Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant (English)

1 reference

7 August 2017

1 reference

16

1 reference

7 August 2017

Kelly-Anne Masterman

10

0 references

Nicole A Mifsud

object named as

Nicole A Mifsud

8

0 references

Lloyd J. Old

17

object named as

Lloyd J Old

1 reference

7 August 2017

Qiyuan Chen

1

1 reference

7 August 2017

Heather Jackson

2

1 reference

7 August 2017

Phillip Parente

3

1 reference

7 August 2017

Tina Luke

4

1 reference

7 August 2017

Mark Rizkalla

5

1 reference

7 August 2017

Tsin Yee Tai

6

1 reference

7 August 2017

He-Cheng Zhu

7

1 reference

7 August 2017

Nektaria Dimopoulos

9

1 reference

7 August 2017

Wendie Hopkins

11

1 reference

7 August 2017

Heather Goldie

12

1 reference

7 August 2017

Eugene Maraskovsky

13

1 reference

7 August 2017

Simon Green

14

1 reference

7 August 2017

Lena Miloradovic

15

1 reference

7 August 2017

Ian D Davis

18

1 reference

7 August 2017

Jonathan Cebon

19

1 reference

7 August 2017

Weisan Chen

20

1 reference

7 August 2017

language of work or name

English

0 references

publication date

14 June 2004

1 reference

Proceedings of the National Academy of Sciences of the United States of America

7 August 2017

1 reference

7 August 2017

101

1 reference

7 August 2017

25

1 reference

7 August 2017

9363-9368

1 reference

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

Rational approaches to human cancer immunotherapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

Novel role of CD8(+) T cells and major histocompatibility complex class I genes in the generation of protective CD4(+) Th1 responses during retrovirus infection in mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine design.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

A listing of human tumor antigens recognized by T cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

Extracellular processing of peptide antigens that bind class I major histocompatibility molecules

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

Help for cytotoxic-T-cell responses is mediated by CD40 signalling.

12 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0403271101

Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0403271101

Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T cell to a fully functional tumor killer cell.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=438982

Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide

26 September 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0403271101

Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0403271101

21 January 2018

Identifiers

DOI

10.1073/PNAS.0403271101

1 reference

7 August 2017

0 references

1 reference

7 August 2017

1 reference